Kamila Landucci Bonifácio

Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson’s disease and its progression: Disease and staging biomarkers and new drug targets

Carine Coneglian de Farias, Michaël Maes, Kamila Landucci Bonifácio et al. · Neuroscience Letters · 2016 · 125 citations · Full text

Major Differences in Neurooxidative and Neuronitrosative Stress Pathways Between Major Depressive Disorder and Types I and II Bipolar Disorder

Michaël Maes, Kamila Landucci Bonifácio, Nayara Rampazzo Morelli et al. · Molecular Neurobiology · 2018 · 105 citations

Major Differences, Stress Hormone, Psychiatry +15

Towards a new model and classification of mood disorders based on risk resilience, neuro-affective toxicity, staging, and phenome features using the nomothetic network psychiatry approach

Michaël Maes, Juliana Brum Moraes, Kamila Landucci Bonifácio et al. · Metabolic Brain Disease · 2021 · 91 citations

Psychiatry, Mood Symptom, Risk Resilience +13

Development of a Novel Staging Model for Affective Disorders Using Partial Least Squares Bootstrapping: Effects of Lipid-Associated Antioxidant Defenses and Neuro-Oxidative Stress

Michaël Maes, Juliana Brum Moraes, Ana Congio et al. · Molecular Neurobiology · 2019 · 83 citations

Neurodegenerative Diseases, Psychiatry, Medicine +11

Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD Are Characterized by Enhanced Nitro-oxidative Stress, Increased Lipid Peroxidation, and Lowered Lipid-Associated Antioxidant Defenses

Michaël Maes, Kamila Landucci Bonifácio, Nayara Rampazzo Morelli et al. · Neurotoxicity Research · 2018 · 80 citations

Comorbid Major Depression, Psychological Co-morbidities, Psychiatry +11